项目名称：长效重组人白细胞介素-2项目 项目简介：总投资2亿元，于2012年底启动建设。目前，该项目建设已进入I期临床研究阶段，预计2018年正式投产。 “公司现有基因工程生产线只生产白细胞...
project name: long-acting recombinant human leukocyte interleukin - 2 project introduction: a total investment of 2 billion yuan, at the end of 2012 start construction. At present, the construction of the project has entered the phase I clinical research phase, is expected to officially put into operation in 2018. "The company's existing genetic engineering production lines only produce white blood cells...
